Corient Capital Partners, LLC Gsk PLC Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Gsk PLC stock. As of the latest transaction made, Corient Capital Partners, LLC holds 7,970 shares of GSK stock, worth $294,969. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,970
Previous 7,970
-0.0%
Holding current value
$294,969
Previous $347,000
-0.0%
% of portfolio
0.03%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding GSK
# of Institutions
20Shares Held
175KCall Options Held
0Put Options Held
0-
Boenning & Scattergood, Inc.43.3KShares$1.6 Million0.3% of portfolio
-
Altium Wealth Management LLC33.4KShares$1.24 Million0.1% of portfolio
-
Advisor Partners LLC Walnut Creek, CA20KShares$739,7180.06% of portfolio
-
Eagle Asset Management Inc St Petersburg, FL16.7KShares$618,8810.0% of portfolio
-
Loveless Wealth Management LLC15KShares$555,5200.43% of portfolio
About GSK PLC
- Ticker GSK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,033,689,984
- Market Cap $75.3B
- Description
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...